Activating mutations or amplification of one of the protein genes, generally PIK3CA gene, and/or inactivating mutations (PTEN) result in constitutive activation of the pathway, a feature distinguishable in less differentiated tumours [34,83,84,85]. This evidence concerns the gene PIK3CA and neoplasm.